ABL Bio Inc. (KOSDAQ:298380)
87,400
+5,800 (7.11%)
Aug 14, 2025, 3:30 PM KST
ABL Bio Revenue
ABL Bio had revenue of 75.74B KRW in the quarter ending June 30, 2025, with 797.21% growth. This brings the company's revenue in the last twelve months to 94.93B, up 188.07% year-over-year. In the year 2024, ABL Bio had annual revenue of 33.40B, down -49.04%.
Revenue (ttm)
94.93B
Revenue Growth
+188.07%
P/S Ratio
50.25
Revenue / Employee
930.69M
Employees
102
Market Cap
4,769.86B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 33.40B | -32.14B | -49.04% |
Dec 31, 2023 | 65.55B | -1.75B | -2.61% |
Dec 31, 2022 | 67.30B | 61.97B | 1,162.19% |
Dec 31, 2021 | 5.33B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition